Safety and efficacy of the farnesoid X receptor (FXR) agonist cilofexor in a proof-of-concept study in patients with compensated cirrhosis due to primary sclerosing cholangitis (PSC)

Autor:	Cynthia Levy, Stephen Caldwell, Parvez Mantry, Velimir Luketic, Charles Landis, Jonathan Huang, Edward Mena, Rahul Maheshwari, Kevin Rank, Jun Xu, Xiangyu Lu, Xiaomin Lu, Chuhan Chung, Robert Myers, Kris Kowdley
Rok vydání:	2022
Předmět:	Hepatology
Zdroj:	Journal of Hepatology. 77:S319-S320
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(22)01004-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::260b5ed92e29e335c6f61fda802e2da9 https://doi.org/10.1016/s0168-8278(22)01004-2 Zobrazit plný text záznamu Full Text from ScienceDirect